Pharma Journalist - Page 758 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Prothena and Celgene to develop new therapies for Neurodegenerative Diseases

Regeneron and Alnylam to Discover New Treatments for Nonalcoholic Steatohepatitis

Seattle Genetics Announces FDA Approval of ADCETRIS (Brentuximab Vedotin)

Merck Announces Appointment of Jennifer Zachary as General Counsel

Horizon Discovery’s Bioproduction Cell Line Used as Part of a Successful Drug (IND) Filing

Bioasis Appoints Deborah Rathjen as Chair of the Board of Directors

Symbiotix Biotherapies Announces License Agreement with Harvard University

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market

FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy

CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA